ENCEPUR

This brand name is authorized in Austria, Estonia, Finland, France, Lithuania, Poland, Romania

Active ingredients

The drug ENCEPUR contains one active pharmaceutical ingredient (API):

1 Inactivated TBE virus, strain K UNII 42XD79UQQ6 - TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)

Encephalitis, tick borne suspension for injection is indicated for the active (prophylactic) immunization of persons of 16 years of age and older against tick-borne encephalitis (TBE). Its pharmacodynamic effect consists of the induction of a sufficiently high concentration of anti-TBE antibody to provide protection against the TBE virus. Read about Encephalitis, tick borne

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BA01	Encephalitis, tick borne, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BA Encephalitis vaccines
Discover more medicines within J07BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1012947, 1037461, 1064797, 1064876, 1078219
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 122638, 170636, 424470, 436303, 436311
Country: FR	Base de données publique des médicaments	Identifier(s): 69431992
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008311, 1011898, 1065124, 1065125, 1068121, 1068122
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100110435, 100192670
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67660001, W67660002, W67660003, W67660004, W67661001, W67661002, W67661003, W67661004